(Q46153193)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19159919%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19159919%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

1 reference

1 reference

Maria Cruz Rodriguez Oroz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19159919%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

C Marin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19159919%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

E Aguilar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19159919%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

G D Bartoszyk

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19159919%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

J A Obeso

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19159919%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

22 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19159919%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

number of pages

10

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19159919%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19159919%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19159919%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

241-250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19159919%20AND%20SRC:MED&resulttype=core&format=json

Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro

20 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1452-9

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1452-9

Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study).

21 January 2018

1 reference

12 December 2020

Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model

1 reference

12 December 2020

Evaluation of EMD 128 130 occupancy of the 5-HT1A and the D2 receptor: a human PET study with [11C]WAY-100635 and [11C]raclopride

1 reference

12 December 2020

The raphe nuclei of the cat brain stem: a topographical atlas of their efferent projections as revealed by autoradiography

1 reference

12 December 2020

Two distinct effects of 5-hydroxytryptamine on single cortical neurons

1 reference

12 December 2020

Coadministration of entacapone with levodopa attenuates the severity of dyskinesias in hemiparkinsonian rats

1 reference

12 December 2020

Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study.

1 reference

12 December 2020

Control of the subthalamic innervation of the rat globus pallidus by D2/3 and D4 dopamine receptors.

1 reference

12 December 2020

Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004

1 reference

12 December 2020

Molecular, pharmacological and functional diversity of 5-HT receptors

1 reference

12 December 2020

Effects of sarizotan on the corticostriatal glutamate pathways.

1 reference

12 December 2020

The subthalamic nucleus in the context of movement disorders

1 reference

12 December 2020

Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei

1 reference

12 December 2020

5-Hydroxytryptamine induced excitation and inhibition in the subthalamic nucleus: action at 5-HT(2C), 5-HT(4) and 5-HT(1A) receptors.

1 reference

12 December 2020

Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.

1 reference

12 December 2020

The novel antidyskinetic drug sarizotan elicits different functional responses at human D2-like dopamine receptors

1 reference

12 December 2020

The functional anatomy of basal ganglia disorders

1 reference

12 December 2020

Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat.

1 reference

12 December 2020

Primate globus pallidus and subthalamic nucleus: functional organization

1 reference

12 December 2020

Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission.

1 reference

12 December 2020

L-Dopa-Induced Release of Cerebral Monoamines

1 reference

12 December 2020

Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson's disease

1 reference

12 December 2020

Levodopa motor complications in Parkinson's disease

1 reference

12 December 2020

Excitatory cortical inputs to pallidal neurons via the subthalamic nucleus in the monkey

1 reference

12 December 2020

A review of central 5-HT receptors and their function

1 reference

12 December 2020

The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy

1 reference

12 December 2020

L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.

1 reference

12 December 2020

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats

1 reference

12 December 2020

Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease

1 reference

12 December 2020

Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease

1 reference

12 December 2020

Influence of serotoninergic drugs on in vivo dopamine extracellular output in rat striatum

1 reference

12 December 2020

Dopamine produced from L-DOPA is degraded by endogenous monoamine oxidase in neurons of the dorsal raphe nucleus of the rat: an immunohistochemical study

1 reference

12 December 2020

Sarizotan, a serotonin 5-HT1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile

1 reference

12 December 2020

Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations

1 reference

12 December 2020

L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function

1 reference

12 December 2020

Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat.

1 reference

12 December 2020

Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease.

1 reference

12 December 2020

Brain monoamines and parkinsonism

1 reference

12 December 2020

Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model.

1 reference

12 December 2020

Immunohistochemical demonstration of serotonin nerve fibers in the subthalamic nucleus of the rat, cat and monkey.

1 reference

12 December 2020

Investigation of the impact of sarizotan on the pharmacokinetics of levodopa

1 reference

12 December 2020

Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder.

1 reference

12 December 2020

Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation

1 reference

12 December 2020

Modulation of spontaneous firing in rat subthalamic neurons by 5-HT receptor subtypes.

1 reference

12 December 2020

Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats

1 reference

12 December 2020

Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA.

1 reference

12 December 2020

Pathophysiology of levodopa-induced dyskinesia: potential for new therapies

1 reference

12 December 2020

Physiology of hypokinetic and hyperkinetic movement disorders: model for dyskinesia.

1 reference

12 December 2020

Thalamic innervation of striatal and subthalamic neurons projecting to the rat entopeduncular nucleus

1 reference

12 December 2020

Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease.

1 reference

12 December 2020

Primate models of movement disorders of basal ganglia origin

1 reference

12 December 2020

Functional and pathophysiological models of the basal ganglia

1 reference

12 December 2020

Synaptic release of dopamine in the subthalamic nucleus

1 reference

12 December 2020

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

12 December 2020

Visual and oculomotor functions of monkey subthalamic nucleus

1 reference

12 December 2020

The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism

1 reference

12 December 2020

Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenousl-DOPA in the rat, with reference to the involvement of aromaticl-amino acid decar☐ylase

1 reference

12 December 2020

Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications

1 reference

12 December 2020

Comparative localization of serotonin1A, 1C, and2 receptor subtype mRNAs in rat brain

1 reference

12 December 2020

MDMA and fenfluramine reduce L-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulation.

1 reference

12 December 2020

5,7-dihydroxytryptamine lesion of the dorsal raphe nucleus alters neuronal activity of the subthalamic nucleus in normal and 6-hydroxydopamine-lesioned rats

1 reference

12 December 2020

Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors

1 reference

12 December 2020

Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey

1 reference

12 December 2020

Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration

1 reference

12 December 2020

The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat.

1 reference

12 December 2020

Effects of L-dopa on efflux of cerebral monoamines from synaptosomes

1 reference

12 December 2020

Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats

1 reference

12 December 2020

10.1007/S00213-008-1452-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19159919%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference